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Abstract. 
 
DNA replication in higher eukaryotic cells
occurs at a large number of discrete sites called replica-
 
tion foci. We have previously puriﬁed a protein, focus-
 
forming activity 1 (FFA-1), which is involved in the
 
assembly of putative prereplication foci in 
 
Xenopus
 
egg extracts. FFA-1 is the orthologue of the Werner
syndrome gene product (WRN), a member of the
 
RecQ helicase family. In this paper we show that FFA-1
colocalizes with sites of DNA synthesis and the single-
stranded DNA binding protein, replication protein A
(RPA), in nuclei reconstituted in the egg extract. In ad-
 
dition, we show that two glutathione 
 
S
 
-transferase FFA-1
fusion proteins can inhibit DNA replication in a domi-
nant negative manner. The dominant negative effect
correlates with the incorporation of the fusion proteins
into replication foci to form “hybrid foci,” which are
unable to engage in DNA replication. At the biochem-
ical level, RPA can interact with FFA-1 and speciﬁcally
stimulates its DNA helicase activity. However, in the
presence of the dominant negative mutant proteins,
the stimulation is prevented. These results provide the
ﬁrst direct biochemical evidence of an important role
for FFA-1 in DNA replication.
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Introduction
 
DNA replication in eukaryotic cells is initiated from a
large number of origins distributed along chromosomes. In
 
Saccharomyces cerevisiae
 
, origins are composed of small
pieces of DNA with specific sequence information. How-
ever, in other eukaryotes the relationship between origins
and specific DNA sequences remains elusive (DePamphi-
lis, 1996). Some studies suggest that metazoan cells utilize
specific DNA sequences as origins, whereas other studies
suggest that replication can initiate from random DNA se-
quences. A careful analysis of these conflicting results has
led to the model that metazoan chromosomes carry many
potential origin sequences, but only a subset of them is ac-
tually selected for usage (DePamphilis, 1993). As to the
mechanism that further selects for an active origin among
the potential ones, it appears that some kind of subnuclear
structure may be involved. One striking feature about
metazoan DNA replication is that it occurs at a large num-
ber of discrete sites called replication foci (or centers, fac-
tories) (Newport and Yan, 1996). The existence of replica-
tion foci was first suggested by fiber autoradiography
studies showing that replication bubbles were almost al-
ways observed in clusters of multiple similar-sized bubbles
rather than single bubbles (Hand, 1978). Such a pattern
could be best explained if multiple consecutive replication
origins were organized into a single unit and then initiated
synchronously. Replication foci were later directly visual-
ized by labeling somatic cells with bromodeoxyuridine or
biotin-dUTP (Nakamura et al., 1986; Nakayasu and Be-
rezney, 1989). The replication-dependent incorporation of
bromodeoxyuridine and biotin-dUTP clearly occurred at a
large number of discrete foci within the nucleus. In addi-
tion, many proteins involved in DNA replication, such as
proliferating cell nuclear antigen (Bravo and Macdonald-
Bravo, 1987; Leonhardt et al., 2000), DNA ligase I (Mon-
tecucco et al., 1995, 1998), CAF-1 (Krude, 1995), DNA
methyltransferase (Leonhardt et al., 1992; Liu et al., 1998),
Cdk2/cyclin A, and replication protein A (RPA)
 
1
 
 (Car-
doso et al., 1993), were found to be associated with these
replication foci during DNA synthesis. Together, these ob-
servations have led to the suggestion that replication foci
are formed by the clustering of multiple replicons. In this
way, a real origin not only may contain certain DNA se-
quence information, but also have to be attached to repli-
cation foci (Newport and Yan, 1996).
 
Despite the consistent observation of replication foci, lit-
tle progress has been made toward understanding how
these foci are assembled and whether they are important
for DNA replication. It is very difficult to address these
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questions in somatic cells using visual observation methods.
Extracts derived from unfertilized eggs, on the other hand,
offer a good model system which allows a biochemical ap-
proach in addition to visual observation. In this system, a
newly introduced DNA substrate, usually demembranated
sperm chromatin, will induce nuclear envelope formation
around itself, and the DNA is then replicated once semi-
conservatively (Lohka and Masui, 1983; Blow and Laskey,
1986; Newport, 1987). As in somatic cells, replication in
these reconstituted nuclei occurs at a large number of dis-
crete foci (Mills et al., 1989; Cox and Laskey, 1991). More-
over, structures similar to replication foci can also form on
chromatin, even in the absence of membrane and conse-
quently DNA replication (Adachi and Laemmli, 1992, 1994;
Yan and Newport, 1995a).
 
 
 
One component of these foci is
the single-stranded DNA binding protein RPA, which is es-
sential for eukaryotic DNA replication (Wold, 1997). By
fractionating the cytosol we have found that RPA associ-
ates with foci on chromatin only in the presence of another
protein, focus forming activity 1 (FFA-1; Yan and Newport,
1995b). Sequence analysis of the gene encoding FFA-1 has
revealed an extensive homology between FFA-1 and the
human Werner syndrome gene product (WRN) throughout
the open reading frame, suggesting that FFA-1 is the true
homologue (orthologue) of human WRN, the only one
known outside mammals (Yan et al., 1998).
Werner syndrome (WS) is associated with the premature
development of a variety of age-related diseases (Schellen-
berg et al., 1998). WRN gene encodes a member of the
RecQ DNA helicase family (Yu et al., 1996), but unlike
other members, it also contains an exonuclease domain
similar to the proofreading exonuclease domain of 
 
Esche-
richia coli
 
 DNA polymerase I (Mushegian et al., 1997). The
protein appears to concentrate in the nucleolus in human
cells, but a nucleoplasmic localization has also been ob-
served (Gray et al., 1998; Marciniak et al., 1998; Shiratori et
al., 1999). However, upon replication arrest WRN migrates
from nucleolus to discrete subnuclear foci characteristic of
replication foci (Constantinou et al., 2000). Biochemical
fractionation of mouse WRN suggests that at least some of
it is associated with a large complex consisting of many rep-
lication proteins (Lebel et al., 1999). In vitro biochemical
studies with recombinant WRN have confirmed that it pos-
sesses both helicase and exonuclease activities (Gray et al.,
1997; Suzuki et al., 1997; Huang et al., 1998; Shen et al.,
1998a,b). In addition, WRN can stimulate the activity of
DNA polymerase 
 
d
 
 (Kamath-Loeb et al., 2000). At the cel-
lular level, WS cells exhibit elevated rates of chromosomal
rearrangements (Hoehn et al., 1975; Salk et al., 1981; Scap-
paticci et al., 1982). The rate of somatic mutations is also in-
creased (Fukuchi et al., 1989, 1990) and most of the muta-
tions appear to be deletions of large segments of DNA
(
 
.
 
20 kb) (Fukuchi et al., 1989). The genomic instability of
WS does not appear to be due to a defect in DNA repair
(Stefanini et al., 1989). Instead, DNA replication appears
to be altered in WS cells: there are fewer initiation events
for replication (Takeuchi et al., 1982a; Hanaoka et al.,
1983), misfiring of origins (Fujiwara et al., 1985), reduced
DNA chain elongation rates (Fujiwara et al., 1977), and a
prolonged S phase (Takeuchi et al., 1982b). Although these
phenotypes are consistent with a replication defect, WRN
is not an essential gene in either humans or mice and as
such the exact function of WRN remains a mystery.
 
With the cloning of FFA-1, we are able to directly test
the function of FFA-1 and replication focus structure in
DNA replication. In this paper we show that FFA-1 colo-
calizes with RPA and sites of DNA synthesis in nuclei re-
constituted in interphase 
 
Xenopus
 
 egg extracts. We also
demonstrate that two glutathione 
 
S
 
-transferase (GST)–
FFA-1 fusion proteins can act in a dominant negative way
to inhibit DNA replication. Interestingly, these two fusion
proteins are incorporated into replication foci to form “hy-
brid foci” that also contain RPA and the endogenous
FFA-1 but are unable to engage in DNA replication. Fi-
nally, we show that RPA can interact with FFA-1 and
strongly stimulate its helicase activity, but this stimulation
is blocked by the two dominant negative fusion proteins.
These results provide the first direct evidence for an im-
portant function of both FFA-1 and replication focus
structure in DNA replication. They also suggest that WS is
caused by defects in the DNA replication process.
 
Materials and Methods
 
Extract Preparation and Nuclei Reconstitution
 
Cytosol and membrane components of 
 
Xenopus
 
 egg extracts and demem-
branated sperm chromatin were prepared according to the procedure de-
scribed by Smythe and Newport (1991). Nuclei were reconstituted at room
temperature (22–24
 
8
 
C) by mixing cytosol (1/3 vol), membrane (1/10 vol),
and ATP-regeneration system/sperm chromatin cocktail (1/10 vol; final
concentration, 2 mM ATP, 20 mM phosphocreatine, 50 
 
m
 
g/ml creatine ki-
nase, and 1,000 
 
m
 
l sperm chromatids). Egg lysis buffer (ELB: 10 mM
Hepes, pH 7.5, 250 mM sucrose, 2.5 mM MgCl
 
2
 
, 50 mM KCl, 1 mM DTT)
was used to make up the volume.
 
Preparation of Recombinant GST Fusion Proteins
 
Various fragments of FFA-1 cDNA were subcloned into the appropriate
pGEX expression vectors downstream of the GST gene to create in frame
fusions. The plasmids were transformed into 
 
E. coli
 
 BL21 (DE3) strain
and the cells were grown at 37
 
8
 
C to OD
 
600
 
 
 
5
 
 0.3 and then induced with 0.5
mM IPTG for 3 h. The fusion proteins were purified on a glutathione af-
finity column following standard procedures (GST Gene Fusion System
[1997]; Amersham Pharmacia Biotech). They were dialyzed three times
against 100 vol of ELB at 4
 
8
 
C, frozen in liquid nitrogen in 5-
 
m
 
l aliquots,
and stored at 
 
2
 
80
 
8
 
C.
 
Antibody Preparation
 
The following antibodies were used in this study: rabbit anti-RPA (all
three subunits), rat anti-RPA (large subunit), rabbit and rat anti–FFA-1
C (amino acids 1030–1436), and rabbit anti-GST. The rabbit anti-RPA
(three subunits) was used directly, without further purification, as de-
scribed previously (Fang and Newport, 1993). All the other antibodies
were raised against the gel-purified recombinant GST fusion proteins ac-
cording to the standard procedure (Goding, 1986). The antibodies were
purified by first passing the sera through the affinity columns containing
the corresponding fusion proteins (the affinity columns were prepared as
described previously [Yan et al., 1993]). The bound antibodies were
eluted with 50 mM glycine (pH 2.5) and then rapidly renatured with 1/10
vol of 1 M Tris
 
.
 
HCl (pH 8). Contaminating antibodies against GST and
other 
 
E. coli
 
 proteins were then removed by another column containing
the total proteins of 
 
E. coli
 
 cells overexpressing GST. Pure anti-GST anti-
body was finally obtained by purifying the contaminating antibodies
eluted from the previous column again on a column containing puri-
fied GST.
 
Indirect Immunofluorescence Staining
 
Indirect immunofluorescence staining was performed as described previ-
ously (Yan and Newport, 1995a). In brief, nuclei were fixed with an equal
volume of 3% formaldehyde (Sigma-Aldrich)/2% sucrose/PBS. After 10
min, they were spun through 1 M sucrose/PBS onto coverslips and then
treated with 0.1% Triton X-100/PBS for 5 min. The coverslips were then 
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blocked with 10% FCS for 20 min and stained with the appropriate pri-
mary and secondary antibodies. For visual assays of DNA replication, 20
 
m
 
M biotin-dCTP (GIBCO BRL) was added to the reaction and detected
by Streptavidin–Texas red (Calbiochem). On average, two focal planes
were required to observe all the foci in one nucleus. Therefore, the total
number of foci was calculated by doubling the number of foci on the focal
plane that cut across the middle of the nucleus. Images were collected
with a monochrome DAGE-MTI cooled CCD-300-RT camera run under
Image v1.6.1 (Scion) and processed in Photoshop
 
®
 
 v5.5 (Adobe Systems).
 
DNA Helicase Assay
 
The substrate for DNA helicase assays is a DNA sequencing reaction
product. In brief, the 
 
2
 
40 sequencing primer was hybridized to ss-M13mp18
DNA and then extended by Sequenase (USB Biochemicals) in the pres-
ence of dNTP, [
 
32
 
P]dATP (NEN Life Science Products), and dilute
ddTTP. The DNA was then purified on microspin S-300 HR columns
(Amersham Pharmacia Biotech) and diluted to 5 ng/
 
m
 
l in TES buffer (10
mM Tris-HCl, pH 8, 1 mM EDTA, 100 mM NaCl). Each reaction contains
5 ng of DNA substrate, 2 mM ATP/MgCl
 
2
 
, and various proteins at the in-
dicated final concentrations. For the helicase inhibition experiments, the
fusion proteins were preincubated with FFA-1 and RPA at room temper-
ature for 20 min before the addition of DNA and ATP. The helicase reac-
tions were terminated after a 30-min incubation at room temperature by
mixing with equal volumes of stop solution (0.5% SDS, 20 mM EDTA)
and then separated on 8% polyacrylamide/TAE gels.
 
Replication Assays
 
Radioactive assays of DNA replication were carried out by including 1
 
m
 
Ci [
 
32
 
P]dATP in each replication reaction. Samples were taken at vari-
 
ous time points, processed with proteinase K, and separated on 1% aga-
rose TAE gels as described previously (Smythe and Newport, 1991). For
replication run-on assays, nuclei were assembled in the presence of 50 
 
m
 
g/
 
m
 
l of aphidicolin (Sigma-Aldrich) for 80 min, diluted two times with PBS,
and spun through 1 M sucrose/PBS onto coverslips. The coverslips were
then placed over 100 
 
m
 
l of dNTP solution (5 mM dATP, dGTP, TTP, and
biotin-dCTP) on parafilm. After 20 s of incubation, they were fixed and
stained for FFA-1 and biotin-dCTP following the same immunofluores-
cence staining procedure as described above.
 
Protein Interaction Assays and Immunoprecipitation
 
For immunoprecipitation, 20 
 
m
 
l of cytosol was diluted to 50 
 
m
 
l with ELB
and then incubated with 10 
 
m
 
l of Affi-gel protein A beads (Bio-Rad Lab-
oratories) precoated with 20 
 
m
 
l of the various antibodies (purified rabbit
anti–FFA-1 C and rabbit IgG, rabbit anti-RPA serum, and preimmune)
at 4
 
8
 
C for 1 h. For the mapping of the interaction domain, 5 
 
m
 
l of the fu-
sion proteins (1 
 
m
 
g) was incubated with 10 
 
m
 
l of cytosol (ELB was added
to make the final volume 30 
 
m
 
l) at room temperature for 1 h. For the in-
teraction between the fusion proteins and the purified RPA, 5 
 
m
 
l of the
fusion proteins (1 
 
m
 
g) was pretreated with 1 
 
m
 
l of DNase I (40 U; Sigma-
Aldrich) or ELB at room temperature for 10 min and then mixed with 5
 
m
 
l of 
 
Xenopus
 
 RPA (0.1 
 
m
 
g; Fang and Newport, 1993) and 19 
 
m
 
l of ELB.
After 1 h at room temperature, the reactions were mixed with 10 
 
m
 
l of
glutathione-agarose beads (Sigma-Aldrich) at 4
 
8
 
C for another 1 h. The
beads (Affi-gel protein A or glutathione-agarose) were brought down by
low speed centrifugation and washed four times with 0.5 ml of ELB
 
 
 
with
0.02% NP-40. The proteins bound to the beads were separated on 8%
SDS-PAGE, transferred to PVDF, probed with the purified rat anti–
FFA-1 C or anti-RPAp70, and detected by SuperSignal chemilumines-
cence (Pierce Chemical Co.).
Figure 1. Colocalization of FFA-1 and RPA in nuclei reconstituted around sperm chromatin in the interphase egg extract. Representa-
tive nuclei from early (40–45 min; A–D), middle (45–85 min; E–H), and late (85–150 min; I–L) stages are shown. (A, E, and I) FFA-1
staining. (B, F, and J) RPA staining. (C, G, and K) Merge of FFA-1 staining and RPA staining. (D, H, and L) DNA staining by Hoechst. 
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Results
 
Colocalization of FFA-1 with RPA and
Replication Foci
 
We first used indirect immunofluorescence staining to es-
tablish the relationship among FFA-1, RPA, and sites of
DNA replication in nuclei reconstituted in 
 
Xenopus
 
 egg
extracts. To do this, nuclei were reconstituted by mixing
demembranated sperm chromatin and egg extracts. After
various lengths of time they were fixed and then stained
for FFA-1, RPA, and DNA synthesis. Replication began
asynchronously, but generally occurred between 45 and 85
min in most nuclei. It was monitored by the incorporation
of biotin-dCTP which was added to the reaction 5 min be-
fore fixation. As shown in Fig. 1, FFA-1 and RPA dis-
played an almost identical spatial distribution throughout
DNA replication. During the early stage (Fig. 1, A–D; 40–
45 min), they formed discrete foci on chromatin. Replica-
tion was not detectable in most nuclei, which is consistent
with the observation that focus structure is formed before
DNA synthesis. But when replication was detected, it oc-
curred at a subset of FFA-1 foci (Fig. 2, A–C), suggesting
that FFA-1 foci are indeed where replication is initiated.
During the middle stage, both FFA-1 and RPA showed a
more diffuse staining colocalizing with chromatin (Fig. 1,
E–H; 45–85 min). Replication proceeded rapidly and was
also detected throughout chromatin (Fig. 2, D–F). The dif-
fuse FFA-1 and RPA staining subsided by the end of this
stage and FFA-1 and RPA could again be detected as foci
which often showed incorporation of biotin-dCTP (data
not shown). During the late stage (after 85 min), replica-
Figure 2. Colocalization of
FFA-1 and sites of DNA syn-
thesis. (A–F) In normal
reconstituted nuclei. Biotin-
dCTP was added 5 min be-
fore fixation. (A–C) 45 min.
(D–F) 60 min. (G–L) In re-
constituted nuclei formed in
the presence of aphidicolin.
(G–I) An aphidicolin-arrested
nucleus directly fixed and
stained. Biotin-dCTP was
added to the reaction at the
beginning. (H–L) An aphidi-
colin-arrested nucleus pel-
leted through 1 M sucrose
cushion and then labeled
with dATP, dGTP, TTP, and
biotin-dCTP. (A, D, G, and
J) FFA-1 staining. (B, E, H,
and K) Biotin staining. (C, F,
I, and L) Merge of FFA-1
staining and biotin staining. 
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tion was no longer detectable (data not shown), the diffuse
staining of FFA-1 and RPA further decreased, but more
discrete foci containing FFA-1 and RPA appeared again
(Fig. 1, I–L) and persisted up to at least 150 min (the max-
imum time assayed).
The more diffuse staining of FFA-1 and RPA was al-
ways observed in the nuclei that displayed extensive DNA
synthesis, suggesting that the two phenomena might be
mechanistically linked. A reasonable explanation is that
during DNA synthesis more single-stranded DNA is gen-
erated, which in turn attracts more RPA and FFA-1 and
the foci consequently appear expanded in size. To test this
hypothesis, we blocked DNA synthesis at the priming step
with aphidicolin, which inhibits DNA polymerases 
 
a
 
 and 
 
d
 
(Melendy and Stillman, 1991). As shown in Fig. 2, G–I,
aphidicolin completely blocked the incorporation of bi-
otin-dCTP, yet FFA-1 foci still formed and their number
increased to 
 
.
 
1,000 after 80 min of incubation. To deter-
mine whether these foci were where replication would
have occurred, we designed a replication run-on experi-
ment based on the observation that replication elongation
resumes synchronously after removal of aphidicolin (Straus-
feld et al., 1994). In brief, the aphidicolin-arrested nuclei
were spun onto a coverslip through a 1 M sucrose cushion.
The nuclei were then incubated with a mixture of dATP,
dGTP, TTP, and biotin-dCTP to allow replication elonga-
tion to resume for a short period of time (usually 20 s). As
shown in Fig. 2, J–L, the sites of biotin-dCTP incorpora-
tion overlapped with FFA-1 foci, suggesting that FFA-1
foci are indeed sites for DNA replication even in the mid-
dle stage nuclei.
 
Immunodepletion of FFA-1 on DNA Replication
 
We then directly tested the role of FFA-1 in DNA replica-
tion by immunodepleting it from egg extracts. As shown in
Fig. 3 A, the anti–FFA-1 antibody but not the control anti-
body removed FFA-1 to a level below detection (
 
.
 
98%
depletion). Yet when assayed for DNA replication in the
nuclei reconstituted with the depleted extracts, no signifi-
cant difference was observed between the two, suggesting
that FFA-1 is not essential for DNA replication (Fig. 3 B).
However, we also failed to notice a significant reduction in
the ability of the FFA-1–depleted extract to form RPA foci
(Fig. 3, C and D). Although it remains formally possible
that our depletion may have been incomplete, in the con-
text that neither human WRN nor its mouse homologue is
an essential gene, this experiment suggests that there is at
least one more focus-forming activity in the egg extract. It
should be mentioned that this result does not contradict
Figure 3. The effect of FFA-1 depletion on DNA replication and
RPA focus formation. (A) Western blot for FFA-1 in the extracts
depleted with either anti–FFA-1 antibody or control antibody.
Arrowhead indicates the position of FFA-1. (B) DNA synthesis
in nuclei reconstituted around sperm chromatin with the de-
pleted extracts. Samples were taken at the times indicated. (C
and D) Immunofluorescence staining for RPA on sperm chroma-
tin incubated in either FFA-1–depleted (C) or control-depleted
cytosol (D).
Figure 4. Effect of GST–FFA-1 fusion protein on DNA replica-
tion. (A) Replication of nuclei reconstituted around sperm chro-
matin in the presence of various fusion proteins (500 nM final
concentration for GST-Xho and GST-Stu/Xho; 1 mM for GST-
Stu and GST) or buffer. The fusion proteins and [32P]dATP were
added at the beginning of the reactions. Samples were taken at
the indicated times and separated on 0.8% agarose/TAE gel. The
top band is the DNA that was too large to enter the gel and the
bottom band is the sheared DNA (.20 kb) introduced during
sample preparation. (B) Diagram of the GST–FFA-1 fusion pro-
teins used in this study. Numbers indicate the positions of the
amino acids that demarcate the various domains in FFA-1. (C)
The fusion proteins used in this study separated on a 12% SDS
polyacrylamide gel and stained by Coomassie blue. Molecular
weight markers are labeled on the right in kilodaltons. 
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our previous report that depletion of FFA-1 blocks RPA
focus formation (Yan et al., 1998). In those experiments we
used partially purified column fractions of RPA and FFA-1
as the starting material for depletion and presumably the
redundant activity had already been removed.
 
Inhibitory Effect of Dominant Negative FFA-1 Mutants 
on DNA Replication in Reconstituted Nuclei
 
Therefore, we tried an alternative approach by using domi-
nant negative mutants. FFA-1’s involvement in focus for-
mation suggests that it should interact with itself and/or
other proteins. Therefore, it should be possible to make mu-
tants that are functionally deficient, but still capable of pro-
tein–protein interaction. Adding such mutant proteins to
the extract may interfere with the function of not only the
endogenous FFA-1 protein but also the redundant protein.
We tested several GST fusion proteins containing vari-
ous regions of FFA-1 (Fig. 4, B and C) for inhibitory ef-
fects on DNA replication. Nuclei were reconstituted in the
extract in the presence of the fusion proteins and
[
 
32
 
P]dATP for various lengths of time. The incorporation
of [
 
32
 
P]dATP into DNA was assayed by running the repli-
cation products on agarose gels. As shown in Fig. 4 A,
GST-Xho (containing FFA-1 amino acids 1–587, just up-
stream of the helicase domain) efficiently inhibited DNA
synthesis (5–10-fold) (Fig. 4 A). GST alone did not exert
any effect on DNA synthesis. The inhibition was most ef-
fective when GST-Xho was added at the beginning of the
reaction and was leaky as DNA synthesis did occur later.
The minimal concentration of GST-Xho to inhibit DNA
synthesis was 
 
z
 
400 nM (data not shown), about 80 times
that of the endogenous FFA-1 (estimated at 5 nM in the
reaction). This is most likely an overestimate, because not
all the fusion protein is in active conformation and the
concentration of the putative redundant protein is not
taken into account.
Although these characteristics are consistent with a
dominant negative effect, there are two potentially trivial
explanations. The first is that GST-Xho nonspecifically in-
activates the egg extract. This is not the case, however,
since nuclear reformation was not significantly affected
(see below; Fig. 5, A–F). The second is that since GST-
Xho contains the putative 3
 
9
 
®
 
5
 
9
 
 exonuclease domain, it
may inhibit replication simply by degrading DNA. To rule
out the this possibility, we expressed and tested a smaller
fusion protein, GST-Stu (containing FFA-1 amino acids
1–296), which still contains the nuclease domain. In vitro
assays indicated that it possessed good 3
 
9
 
®
 
5
 
9
 
 exonuclease
activity (data not shown). However, it did not exert any
significant inhibitory effect on DNA replication in recon-
stituted nuclei even at twice the molar concentration of
GST-Xho (Fig. 4 A). This result suggests that the inhibi-
tory domain is located in the region spanning amino acids
297–587, which lies between the nuclease domain and the
helicase domain. When the GST fusion protein containing
this region (GST-Stu/Xho) was expressed and tested, it in-
deed effectively inhibited DNA replication at about the
same concentration as that of GST-Xho (Fig. 4 A). To-
gether these experiments, in combination with the immuno-
fluorescence studies, strongly suggest that FFA-1 partici-
pates in DNA replication in reconstituted nuclei.
 
Formation of Hybrid Replication Foci
 
The presence of FFA-1 at replication foci raises the ques-
tion of whether the inhibitory fusion proteins block DNA
replication by interfering with the assembly, or the activity
of replication foci. To address this issue, we determined
the localization of the GST-Xho fusion protein by immuno-
fluorescence staining. Interestingly, GST-Xho was itself
incorporated into 300–500 discrete foci (Fig. 5, A–F). The
GST-Xho foci were mostly hybrid in nature because they
also contained RPA (Fig. 5 B) and the endogenous FFA-1
(Fig. 5 E). They were well formed by 52 min, but did not
show incorporation of biotin-dCTP, whereas extensive in-
corporation of biotin-dCTP had already occurred by this
time in the control nuclei. In addition, whereas normal foci
tend to expand in size during DNA synthesis, the GST foci
changed very little in size upon further incubation (data
not shown).
In support of the correlation between the formation of
“hybrid foci” and the inhibitory effect on replication, we
found that the number of foci containing GST-Xho per
nucleus decreased dramatically from 300–500 at 400 nM
down to 
 
,
 
50 at 100 nM, which correlates well with the
precipitous drop in replication inhibition by GST-Xho at
the lower concentration (data not shown). Moreover, we
found that GST-Stu/Xho, which can inhibit DNA replica-
tion, also induced the formation of hybrid foci within re-
constituted nuclei (Fig. 5, G–I). In contrast, GST and
GST-Stu, which cannot inhibit DNA replication, could not
form any foci detectable by the anti-GST antibody (Fig. 5,
J–O). Together, these observations strongly suggest that
the Stu/Xho domain inhibits DNA replication by forming
“hybrid foci” that are incapable of executing DNA syn-
thesis.
 
Physical Interaction between FFA-1 and RPA
 
We then studied the biochemical mechanism by which the
dominant negative fusion proteins inhibit DNA synthesis
at “hybrid foci.” The simplest explanation is that the fusion
proteins displace the endogenous FFA-1 and the redun-
dant protein from “hybrid foci.” However, since the en-
dogenous FFA-1 is still present at “hybrid foci,” this expla-
nation is unlikely to be the case. The second explanation is
that, since helicases usually act as oligomers, the dominant
negative fusion proteins, which do not contain the helicase
domain, might interact with the endogenous FFA-1, lead-
ing to the formation of inactive helicase oligomers. We
have tested this idea, but found no interaction between the
fusion proteins and FFA-1 (data not shown); as such it is
also unlikely to be true. The third explanation is based on
the report that the helicase activity of human WRN can be
stimulated by the human RPA protein, probably by pro-
tein–protein interaction (Shen et al., 1998b; Brosh et al.,
1999). Conceivably, the helicase activity of FFA-1 may also
be stimulated by RPA through protein–protein interac-
tion. If the dominant negative fusion proteins can also in-
teract with RPA, they may then interfere with this stimula-
tion. To test this idea, we first determined whether FFA-1
could indeed interact with RPA by coimmunoprecipita-
tion. Protein A beads were coated with different antibod-
ies and then incubated with the cytosol. The proteins
bound to the beads were then separated on SDS-PAGE, 
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transferred to PVDF membranes, and probed with either
anti–FFA-1 or anti-RPA antibodies. As shown in Fig. 6 A,
the anti–FFA-1 antibody brought down not only FFA-1,
but also a small amount of RPA. Conversely, the anti-RPA
antibody brought down RPA and a small amount of FFA-1.
In neither case did the control antibody bring down FFA-1
and RPA. This experiment suggests that FFA-1 and RPA
can physically interact with each other.
Figure 5. Formation of hy-
brid foci. (A–F) Nuclei were
reconstituted around sperm
chromatin for 52 min in the
presence of GST-Xho and
stained with the affinity-puri-
fied anti-GST (A and D),
RPA (B), or FFA-1 (E). (C)
Merge of GST staining and
RPA staining. (F) Merge of
GST staining and FFA-1
staining. The anti–FFA-1 an-
tibody is against the COOH-
terminal end of FFA-1 and
does not react with GST-
Xho. (G–O) Nuclei reconsti-
tuted in the presence of
GST-Stu/Xho (G–I), GST-
Stu (J–L), and GST (M–O)
for 52 min. (G, J, and M)
GST staining (green). (H, K,
and N) RPA staining (red).
(I, L, and O) Merge of GST
and RPA staining. 
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We then determined which region of FFA-1 mediates its
interaction with RPA. Various GST–FFA-1 fusion proteins
were incubated in the cytosol and then brought down by
glutathione-agarose beads. Proteins bound to the beads
were analyzed by Western blot for the presence of RPA. As
shown in Fig. 6 B, RPA was efficiently brought down with
GST-Xho and GST-Stu/Xho, but not with GST or GST-Stu.
Two other fusions containing the middle and COOH-termi-
nal regions of FFA-1 also failed to bring down RPA (data
not shown). Therefore, the Stu/Xho domain, which can in-
hibit DNA replication and induce the formation of “hybrid
foci,” also mediates FFA-1’s interaction with RPA. Further
characterization revealed that the interaction can still be
observed between the fusion proteins and the purified
RPA, and in the presence of DNase I (Fig. 6 C), suggesting
that it is by direct contact, rather than indirectly mediated
by other proteins or DNA. These results are consistent with
 
the colocalization of FFA-1, RPA, and the GST fusions
containing the Stu/Xho domain at “hybrid foci.”
The direct interaction between the Stu/Xho domain and
RPA raised the possibility that replication inhibition is
due to the titration of RPA, rather than the interference
with FFA-1 activity. To test this possibility, we determined
whether RPA was completely bound to the GST-Stu/Xho
fusion protein in the pull-down assay. As shown in Fig. 6
D, at the concentration effective for replication inhibition,
the fusion protein bound to only a small fraction of RPA
(
 
z
 
10%). This result suggests that FFA-1 interacts with
only a subset of RPA and the dominant negative effect is
not due to the titration of RPA.
 
Functional Effect of FFA-1–RPA Interaction on FFA-1 
Helicase Activity
 
We then determined whether the interaction between
FFA-1 and RPA could augment the DNA helicase activ-
ity of FFA-1. FFA-1 was incubated with a radioactively la-
beled DNA substrate and various amounts of RPA in the
presence of ATP. The substrate was made by extending a
primer hybridized to single-stranded m13 DNA in the
presence of [
 
32
 
P]dATP, dNTPs, and dilute ddTTP. The ra-
tionale for using this type of substrate is that RPA may
preferentially stimulate the unwinding of long DNA
strands. After incubation, the reactions were terminated
and separated on 8% polyacrylamide gels. The undissoci-
ated fragments could not enter the gel due to the large
size of m13 DNA, whereas the dissociated fragments
would run as a series of bands of different sizes. As shown
in Fig. 7 A, FFA-1 alone showed very weak unwinding ac-
tivity at the concentration used in this experiment (
 
z
 
2
nM). However, the unwinding of both short and long frag-
ments was greatly stimulated by RPA at a concentration
as low as 60 nM. RPA alone, even at the highest concen-
tration (120 nM), did not cause any significant dissociation
of the substrate.
Figure 6. Interaction between FFA-1 and RPA. (A) Coimmuno-
precipitation of FFA-1 and RPA. Western blot analysis of the
proteins brought down from the cytosol by the Affi-gel protein A
beads precoated with the indicated antibodies. Blots were probed
with the rabbit anti–FFA-1C (top) and rabbit anti-RPA (bot-
tom). (B) Mapping of the RPA interaction domain in FFA-1.
The various GST–FFA-1 fusion proteins were incubated with the
cytosol and then brought down by glutathione beads. The bound
proteins were then subject to Western blot analysis with the puri-
fied rat anti-RPA antibody. (C) Interaction between GST-Xho
and the purified Xenopus RPA in the presence or absence of
DNase I. The proteins brought down by glutathione beads were
analyzed by Western blot with the purified rat anti-RPA anti-
body. (D) Amount of RPA bound to GST-Stu/Xho. GST-Stu/
Xho (500 nM) was incubated with 5 ml of cytosol in a 15-ml reac-
tion and then brought down by glutathione beads. Indicated
amounts (as percentages of cytosol) of the beads and supernatant
fractions were analyzed by Western blot with the purified rat
anti-RPA antibody.
Figure 7. Effect of RPA and gp32 on the helicase activity of
FFA-1. (A) Helicase reactions containing the indicated amounts
of FFA-1 and RPA (in nM). (B) Helicase reactions containing
the indicated amounts of FFA-1 (in nM) and gp32 (in mM). In
both A and B, the second lanes from the right contain buffer
only, whereas the rightmost lanes contain the heated DNA sub-
strate. All the reactions also contain 2.5 mM (in nucleotides)
DNA and 2 mM ATP. Indicated on the left of each gel are the
migration positions of double-stranded DNA markers. 
Chen et al. 
 
FFA-1 and DNA Replication
 
993
 
There are two likely mechanisms to explain how RPA
might stimulate FFA-1 helicase activity. The more trivial
explanation is that RPA simply prevents the dissociated
DNA from reassociation. Alternatively, the effect may be
due to the specific interaction between the two proteins.
To differentiate between these two possibilities, we tested
the effect on FFA-1 helicase activity by another single-
stranded DNA binding protein, the gene 32 protein of 
 
E.
coli
 
 phage T4 (gp32). As shown in Fig. 7 B, this protein
had no significant stimulatory effect on the unwinding re-
action over a wide range of concentrations (from 37.5 nM
to 3 
 
m
 
M). The size of binding site of gp32 is seven nucle-
otides (Ferrari et al., 1994), so 3 
 
m
 
M of protein is in 
 
z
 
10-
fold excess over the number of binding sites. In contrast,
assuming that the size of binding site of 
 
Xenopus
 
 RPA is
similar to that of human RPA (30 nucleotides; Wold,
1997), 60 nM of RPA occupies at most 75% of the binding
sites. These results suggest that the stimulation on FFA-1
helicase activity by RPA depends on the direct interaction
between the two proteins.
 
Effect of GST–FFA-1 Fusion Proteins on FFA-1/RPA 
Helicase Activity
 
Since GST-Xho and GST-Stu/Xho can interact with RPA,
we then addressed whether they can inhibit the stimulation
of FFA-1 helicase activity by RPA. To do this, various
amounts of the fusion proteins were added to the helicase re-
action containing FFA-1 and RPA. As shown in Fig. 8 A,
GST-Xho and GST-Stu/Xho inhibited the unwinding reac-
tion in a dose-dependent manner. In contrast, GST-Stu had
no effect on unwinding, even at the highest concentration
(2.4 
 
m
 
M). In the absence of RPA, FFA-1 had a low intrinsic
helicase activity, particularly on small fragments. But as
shown in Fig. 8 B, this activity was not significantly affected
by the fusion proteins. In addition, the affinity of RPA for
single-stranded DNA was not affected by the fusion proteins
(data not shown). Collectively, these results support the in-
terpretation that RPA stimulates FFA-1 through direct pro-
tein–protein interaction and this stimulation is blocked by
the two fusion proteins containing the Stu/Xho domain.
 
It is worth mentioning that the concentrations of the
proteins in the helicase inhibition experiment agree rea-
sonably well with those in the replication inhibition exper-
iment. In the helicase experiment, the concentrations for
FFA-1, RPA, and the two dominant negative fusion pro-
teins are 2, 60, and 300 nM (minimum), respectively. In the
replication experiment, the corresponding concentrations
are 5, 33, and 400 nM (minimum). Therefore, it is reason-
able to believe that the FFA-1 helicase activity is also stim-
ulated by RPA during normal DNA replication and that
this stimulation is abolished by the two dominant negative
fusion proteins at “hybrid foci.”
 
Discussion
 
Summary
 
In this paper, we have shown that FFA-1 colocalizes with
RPA foci from which DNA replication then initiates in nu-
clei reconstituted in 
 
Xenopus
 
 egg extracts. In addition, we
have found that two fusion proteins containing the Stu/Xho
domain of FFA-1 can act in a dominant negative manner to
block DNA replication in reconstituted nuclei. These re-
sults strongly suggest that FFA-1 participates in DNA rep-
lication. At the biochemical level, we have confirmed that
RPA can physically interact with FFA-1 and greatly stimu-
lates its helicase activity. As to the mechanism of the domi-
nant negative effect by the two fusion proteins, we have ob-
served that they can be incorporated into foci to form
“hybrid foci” that are unable to engage in DNA synthesis.
Interestingly, the same Stu/Xho domain that mediates the
inhibition of DNA replication also mediates the interaction
between FFA-1 and RPA. Moreover, the two inhibitory fu-
sion proteins can block the stimulation of FFA-1 DNA he-
licase activity by RPA, presumably by competing against
the endogenous FFA-1 protein for interaction with RPA.
 
FFA-1 Helicase and DNA Replication
The results with the dominant negative mutants and immu-
nofluorescence staining strongly suggest that FFA-1 plays
Figure 8. Effect of GST–FFA-1 fusion proteins
on FFA-1 helicase activity. (A) In the presence
of RPA. Lanes 1–10 contain 2 nM FFA-1 and 60
nM RPA, but lanes 1–9 also contain the various
fusion proteins at the indicated final concentra-
tions (in mM). Lane 11 contains the substrate in-
cubated in buffer only and lane 12 contains the
heated substrate. (B) In the absence of RPA.
Lanes 1–3 contain 5 nM FFA-1 and GST-Xho
(0.75 mM), GST-Stu/Xho (0.75 mM), and GST-
Stu (1.5 mM). Lane 4 contains 5 nM FFA-1 only,
lane 5 contains the substrate incubated in buffer
only, and lane 6 contains the heated substrate.
More FFA-1 was used in this experiment to bet-
ter detect the weak helicase activity in the ab-
sence of RPA. The film was also exposed four
times as long as that of A. All the reactions con-
tain 2.5 mM DNA and 2 mM ATP.The Journal of Cell Biology, Volume 152, 2001 994
an important role in DNA replication. In support of this
conclusion, human WS cells display many phenotypes that
are consistent with defects in DNA replication (Schellen-
berg et al., 1998). In addition, biochemical fractionation of
mouse WRN suggests that it is present in “replisome,” a
large complex consisting of many replication proteins,
including proliferating cell nuclear antigen and topo-
isomerase I (Lebel et al., 1999). It has also been demon-
strated recently that human WRN can stimulate DNA
polymerase d (Kamath-Loeb et al., 2000). Therefore, it is
reasonable to conclude that at least one function for FFA-1
and WRN is in DNA replication. The unsettled issue is
whether this function is essential for or only peripheral to
DNA replication. Our depletion data suggest that removal
of FFA-1 from total interphase extracts yields only a minor
effect on DNA replication. Similarly, neither human nor
mouse WRN gene is essential for cell viability. Although
these observations indicate that FFA-1 and WRN are not
essential for DNA replication, they do not necessarily sug-
gest that the function executed by FFA-1 and WRN is not
essential. Considering that WRN is only one of five known
RecQ family members in human cells, it is very likely that
other members can partially compensate for the loss of
WRN and FFA-1. In support of this hypothesis, the FFA-1
depletion experiment suggests that there is at least one ad-
ditional focus-forming activity in Xenopus egg extracts.
Similarly, in S. cerevisiae, two helicases, SGS1 and SRS2,
are partially redundant to each other and disruption of
both genes causes cells to arrest with an unreplicated ge-
nome (Lee et al., 1999) or a slow growth phenotype (Gan-
gloff et al., 2000). Although SGS1 is a RecQ family mem-
ber, SRS2 is not, suggesting that the redundant protein for
FFA-1 and WRN does not have to be a RecQ family mem-
ber. In higher eukaryotes, database searches have not de-
tected any protein with extensive homology to Srs2 so far,
yet a functional homologue of SRS2 may still exist.
Nature of RPA Foci in Egg Extracts
RPA foci can form on sperm chromatin in interphase cyto-
sol in the absence of membranes (Adachi and Laemmli,
1992). Because DNA replication does not occur under this
condition, it is assumed that these RPA foci are formed
“prereplicatively.” Later studies in mammalian cells de-
tected RPA foci in S phase, but not G1 phase nuclei (Dim-
itrova et al., 1999). One simple explanation is that the
RPA foci formed in the absence of membranes are quali-
tatively different from the replication foci formed inside
reconstituted nuclei. However, there is another likely ex-
planation. If replication forks are arrested with aphidi-
colin, a large number of FFA-1 (and RPA) containing foci
are observed. The minimal number is 1,000 per nucleus,
whereas in many nuclei the staining has a granular appear-
ance, suggesting an even higher number of foci. This is
much more than what can be formed on sperm chromatin
decondensed in cytosol only (at most 200 per sperm chro-
matin; Adachi and Laemmli, 1992; Yan and Newport,
1995a). Therefore, the optimal condition for focus forma-
tion is inside reconstituted nuclei (which are equivalent to
S phase nuclei in somatic cells), whereas the foci formed in
cytosol alone most likely represent the basal level due to
the large amount of replication proteins stockpiled in eggs.
In somatic cells, replication proteins are not overproduced
and therefore only S phase nuclei provide the right condi-
tion for efficient RPA focus formation.
Replication Foci and DNA Replication
Replication foci have been observed by many laboratories
with various detection methods, but their importance in
DNA replication has not been determined. The data in
this paper suggest that replication foci do play an impor-
tant role in DNA replication. Immunofluorescence stain-
ing suggests that replication does occur at foci containing
RPA and FFA-1. Moreover, the two dominant negative
mutant proteins do not block the assembly of replication
foci, but instead are incorporated into the so-called “hy-
brid foci,” which also contain RPA and the endogenous
FFA-1. At the biochemical level, our data suggest that the
inhibition on DNA replication is due, at least in part, to
the block of stimulation of FFA-1 helicase activity by
RPA. Presumably, at normal foci the helicase activity of
FFA-1 is greatly stimulated by the interaction with RPA.
At “hybrid foci,” however, we infer that FFA-1 cannot in-
teract with RPA due to competition from the fusion pro-
teins and consequently cannot efficiently unwind DNA.
FFA-1 and Other Replicative Helicases
As a DNA helicase, one role of FFA-1 in DNA replication
is presumably to unwind DNA. What then is the relation-
ship between FFA-1 and the other helicases, such as the
mini-chromosome maintenance proteins which are also
implicated in DNA replication (Tye, 1999)? Although in
vitro replication of small genomes like SV40 DNA in-
volves only one replicative helicase, accumulating evi-
dence suggests that in vivo replication of genomic DNA
requires multiple helicases. In S. cerevisiae, in addition to
the MCMs, SGS1, and SRS2, the DNA2 helicase is also re-
quired for DNA replication and appears to be involved in
the maturation of Okazaki fragments (Budd et al., 1995;
Budd and Campbell, 1997). In addition, two other heli-
cases, PIF1 and RRM3, participate in the replication of
rDNA regions with opposing roles. Although RRM3 pro-
motes replication fork progression throughout rDNA,
PIF1 stops the leftward fork movement at the replication
fork barrier located near the 39 end of the 35S transcrip-
tion unit (Ivessa et al., 2000). The multitude of helicases
involved in cellular DNA replication is probably an adap-
tation to the enormous complexity of genomic DNA, both
in size and in organization. Conceivably, in eukaryotic
cells, the MCMs may facilitate in the initial unwinding of
origins, but other helicases, like SGS1, SRS2, or DNA2,
may take over at a later stage. In addition, certain regions
like the rDNA repeat locus may be compacted differently
from the rest of the genome and may require special heli-
cases, like PIF1 and RRM3, to properly unwind them
without irreversibly disrupting the local chromatin organi-
zation. As to FFA-1 and WRN, one likely role for them is
to organize replication foci. But since FFA-1 associates
with DNA throughout replication and human WRN inter-
acts with other replication proteins and stimulates DNA
polymerase d, FFA-1 and WRN may also participate in the
elongation stage. As to the potential mechanistic role in
elongation, Constantinou et al. (2000) have recently re-
ported that WRN has an activity to translocate Holliday
junction and, upon replication arrest, it migrates from nu-Chen et al. FFA-1 and DNA Replication 995
cleolus to discrete RPA-containing subnuclear foci charac-
teristic of replication foci. In addition, genetic analyses in
E. coli, budding yeast, and fission yeast suggest that RecQ
type of helicases is involved in the stabilization of replica-
tion forks (Stewart et al., 1997; Courcelle and Hanawalt,
1999; Frei and Gasser, 2000). In particular, the slow
growth phenotype of Sgs1 Srs2 double mutant can be res-
cued by the inactivation of the homologous recombination
pathway (Gangloff et al., 2000). Together, these observa-
tions suggest that FFA-1 and WRN may protect stalled
replication forks from aberrant recombination events.
These events are probably rare in normal somatic cells,
but more prevalent in nuclei reconstituted in egg extracts
owing to the much larger number of replication forks in
the latter system. Further study is required to uncover the
details of how FFA-1/WRN and other RecQ helicases co-
ordinate the replication machinery and the recombination
machinery to ensure the accurate duplication of cellu-
lar DNA.
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